BTAI
BioXcel Therapeutics Inc
NASDAQ: BTAI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.04
-1.89% today
Updated 2026-04-29
Market cap
$28.70M
P/E ratio
—
P/S ratio
44.70x
EPS (TTM)
$-5.73
Dividend yield
—
52W range
$1 – $8
Volume
1.8M
BioXcel Therapeutics Inc (BTAI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $24.00 | $0.00 | $375000.00 | $1.38M | $2.27M | $642000.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | -100.0% | — | +268.0% | +64.2% | -71.7% |
| Cost of revenue | — | $0.00 | $1000.00 | $17000.00 | $156000.00 | $188000.00 | $297000.00 | $20000.00 | $1.26M | $2.14M | $464000.00 |
| Gross profit | — | $0.00 | $-1000.00 | $-17000.00 | $-156000.00 | $24.00 | $-297000.00 | $355000.00 | $120000.00 | $123000.00 | $178000.00 |
| Gross margin | — | — | — | — | — | 100.0% | — | 94.7% | 8.7% | 5.4% | 27.7% |
| R&D | $233000.00 | $1.40M | $2.69M | $14.56M | $25.80M | $57.99M | $52.71M | $91.24M | $84.33M | $30.43M | $30.25M |
| SG&A | $403000.00 | $721000.00 | $1.85M | $5.40M | $7.80M | $24.30M | $54.23M | $55.76M | $63.51M | $33.10M | $20.49M |
| Operating income | $-636000.00 | $-2.12M | $-4.54M | $-19.96M | $-33.60M | $-82.30M | $-106.94M | $-159.65M | $-171.78M | $-67.25M | $-49.70M |
| Operating margin | — | — | — | — | — | -342904166.7% | — | -42572.0% | -12448.0% | -2967.6% | -7742.2% |
| EBITDA | $-636000.00 | $-2.12M | $-4.54M | $-19.25M | $-32.81M | $-82.11M | $-106.64M | $-157.22M | $-165.42M | $-44.16M | $-49.41M |
| EBITDA margin | — | — | — | — | — | -342120833.3% | — | -41924.5% | -11987.0% | -1948.9% | -7695.5% |
| EBIT | — | $-2.12M | $-4.54M | $-19.27M | $-32.97M | $-82.30M | $-106.94M | $-157.54M | $-165.74M | $-44.47M | $-49.70M |
| Interest expense | $0.00 | $0.00 | $2000.00 | $0.00 | $0.00 | $27000.00 | $40000.00 | $8.21M | $13.31M | $15.13M | $16.98M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-636000.00 | $-2.12M | $-4.54M | $-19.27M | $-32.34M | $-82.01M | $-106.63M | $-165.76M | $-179.05M | $-59.60M | $-69.90M |
| Net income growth (YoY) | — | -233.3% | -114.1% | -324.5% | -67.8% | -153.6% | -30.0% | -55.5% | -8.0% | +66.7% | -17.3% |
| Profit margin | — | — | — | — | — | -341700000.0% | — | -44201.9% | -12974.9% | -2630.1% | -10887.4% |